ArticleBMJ open gastroenterology2026

Escalating anti-tumour necrosis factor exposure with reductions in surgical resection rates in paediatric inflammatory bowel disease: an 18-year real-world population-based cohort study.

Zachary Green et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.